(NEW YORK)As growth slows in shares of large-cap biotechs and economic woes weigh on the broader markets, investors can find dramatic growth opportunities in many small and midcap biotechs w...READ MORE
(NEW YORK)Drug developer Curis Inc. said Monday it will receive a $3 million cash payment from partner Genentech Inc. as that company starts a midstage study on a potential colon cancer drug...READ MORE